Asymchem Laboratories (Tianjin) Co., Ltd.
002821
Kedudukan dalam Saham
#2511
Asymchem Laboratories (Tianjin) Co., Ltd. functions as a contract development... Asymchem Laboratories (Tianjin) Co., Ltd. functions as a contract development and manufacturing organization (CDMO), offering its expertise to pharmaceutical and biotechnology companies both globally and within Mainland China. Their services encompass drug research, development, and production, supporting projects across the entire drug lifecycle, from early clinical phases to commercial scale. This includes R&D and cGMP-compliant manufacturing of advanced intermediates, active pharmaceutical ingredients (APIs), and finished drug formulations, in addition to providing clinical research support. Furthermore, Asymchem engages in pharmaceutical analysis and testing, the distribution (wholesale, retail, and direct sale) of medicines, and initiatives focused on advancing pharmaceutical science and technology. The company, established in 1999, maintains its headquarters in Tianjin, China.
Harga Saham
$20.91
Modal Pasaran
$7.57B
Perubahan (1 hari)
-8.26%
Perubahan (1 tahun)
41.25%
Negara
CN
Perdagangan Asymchem Laboratories (Tianjin) Co., Ltd. (002821)
Kategori
Healthcare
Pendapatan untuk Asymchem Laboratories (Tianjin) Co., Ltd. (002821)
Pendapatan pada Jun 2026 TTM: $175.62M
Menurut laporan kewangan terkini Asymchem Laboratories (Tianjin) Co., Ltd., pendapatan semasa syarikat ialah $175.62M. Pada tahun 2024, syarikat memperoleh pendapatan sebanyak $146.92M, penurunan berbanding pendapatan pada tahun 2023 yang berjumlah $361.25M. Pendapatan yang dipaparkan di halaman ini adalah pendapatan sebelum faedah dan cukai atau dikenali sebagai EBIT.
Sejarah pendapatan bagi Asymchem Laboratories (Tianjin) Co., Ltd. dari 2011 hingga 2026
Pendapatan pada akhir setiap tahun
| Tahun | Pendapatan | Ubah |
|---|---|---|
| 2026 (TTM) | $175.62M | -4.48% |
| 2025 | $183.86M | 25.15% |
| 2024 | $146.92M | -59.33% |
| 2023 | $361.25M | -33.10% |
| 2022 | $540.01M | 187.71% |
| 2021 | $187.69M | 51.14% |
| 2020 | $124.18M | 38.67% |
| 2019 | $89.55M | 33.73% |
| 2018 | $66.96M | 3.22% |
| 2017 | $64.87M | 38.39% |
| 2016 | $46.88M | 52.55% |
| 2015 | $30.73M | 43.65% |
| 2014 | $21.39M | 28.73% |
| 2013 | $16.62M | 23.63% |
| 2012 | $13.44M | -5.39% |
| 2011 | $14.21M | 0.00% |
Pendapatan untuk syarikat atau pesaing serupa
| Syarikat | Pendapatan | Perbezaan Pendapatan | Negara |
|---|---|---|---|
| $5.27B | 2,903.53% |
US
|
|
| $-3.09B | -1,857.74% |
US
|
|
| $-4.02B | -2,386.83% |
AU
|
|
| $3.01B | 1,611.46% |
BE
|
|
| $1.95B | 1,010.70% |
NL
|
